The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial

per Barroso-Sousa, R., Barry, W.T., Guo, H., Dillon, D., Tan, Y.B., Fuhrman, K., Osmani, W., Getz, A., Baltay, M., Dang, C., Yardley, D., Moy, B., Marcom, P.K., Mittendorf, E.A., Krop, I.E., Winer, E.P., Tolaney, S.M.
Publicat a Ann Oncol (2019)

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized pha...

per Han, H S, Diéras, V, Robson, M, Palácová, M, Marcom, P K, Jager, A, Bondarenko, I, Citrin, D, Campone, M, Telli, M L, Domchek, S M, Friedlander, M, Kaufman, B, Garber, J E, Shparyk, Y, Chmielowska, E, Jakobsen, E H, Kaklamani, V, Gradishar, W, Ratajczak, C K, Nickner, C, Qin, Q, Qian, J, Shepherd, S P, Isakoff, S J, Puhalla, S
Publicat a Ann Oncol (2018)